論文

2012 英文

TITLE & JOURNAL/AUTHORS

• Histopathological Diagnosis of Early HCC through Biopsy: Efficacy of Victoria Blue and Cytokeratin 7 Staining.
  著者名：Kobayashi S, Kim SR, Imoto S, Ando K, Hirakawa M, Saito J, Fukuda K, Otono Y, Sakaki M, Tsuchida S, Kim SK, Hayashi Y, Nakano M, Kudo M.
  出版物名：Dig Dis. 2012;30(6):574-9. doi: 10.1159/000343069. Epub 2012 Dec 13.
• Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease.
  著者名：Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, et al. (2012)
  出版物名：Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose. Liver Disease.
  PLoS ONE 7(10): e48366. doi:10.1371/journal.pone.0048366 Epub 2012 Oct 31.
• Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis.
  著者名：Hayashi F, Momoki C, Yuikawa M, Simotani Y, Kawamura E, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N, Ohfuji S, Fukusima W, Habu D.
  出版物名：World J Gastroenterol. 2012 October 28; 18(40): 5759–5770.
• High Prevalence of Gastroesophageal Reflux Symptoms in Patients with Non-Alcoholic Fatty Liver Disease Associated with Serum Levels of Triglyceride and Cholesterol but Not Simple Visceral Obesity.
  著者名：Fujikawa Y, Tominaga K, Fujii H, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Fujiwara Y, Matsuura T, Kawada N, Arakawa T.
  出版物名：Digestion. 2012 Sep 5;86(3):228-237.
• Anti-hepatitis B virus therapy: To stop, or not to stop: Has the question been solved?
  著者名：Kozuka R, Enomoto M, Morikawa H, Tamori A, Kawada N.
  出版物名：Hepatol Res. 2012 Sep;42(9):946-7.
• Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.
  著者名：Enomoto M, Nishiguchi S, Tamori A, Kobayashi S, Sakaguchi H, Shiomi S, Kim SR, Enomoto H, Saito M, Imanishi H, Kawada N.
  出版物名：J Gastroenterol. 2012 Aug 2. [Epub ahead of print]
• Inhibition of the activation of hepatic stellate cells by arundic acid via the induction of cytoglobin.
  著者名：Cui W, Wang M, Maegawa H, Teranishi Y, Kawada N.
  出版物名：Biochem Biophys Res Commun. 2012 Aug 31;425(3):642-8.
• Induction of microRNA-214-5p in human and rodent liver fibrosis.
  著者名：Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, Kawada N.
  出版物名：Fibrogenesis Tissue Repair. 2012 Aug 1;5(1):12.
• Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C.
  著者名：Ohfuji S, Fukushima W, Tamori A, Maeda K, Maeda A, Hirota Y.
  出版物名：Influenza Other Respi Viruses. 2012 Aug 16.
• Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.
  著者名：Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M.
  出版物名：PLoS One. 2012;7(6):e39175. Epub 2012 Jun 21.
• Changes in sequences of core region, interferon sensitivity-determining region and interferon and ribavirin resistance-determining region of hepatitis C virus genotype 1 during interferon-alpha and ribavirin therapy, and efficacy of retreatment.
  著者名：Kozuka R, Enomoto M, Hai H, Ogawa T, Nakaya M, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Tamori A, Kawada N.
  出版物名：Hepatol Res. 2012 May 3. doi: 10.1111/j.1872-034X.2012.01046.x.
  [Epub ahead of print]
• Antifibrotic role of macrophage migration inhibitory factor: discovery of an unexpected function.
  著者名：Thuy le TT, Kawada N.
  出版物名：Hepatology. 2012 Apr;55(4):1295-7.
• Effect of mosapride citrate on gastric emptying in interferon-induced gastroparesis.
  著者名：Kawamura E, Enomoto M, Kotani K, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Kawabe J, Tominaga K, Tamori A, Shiomi S, Kawada N.
  出版物名：Dig Dis Sci. 2012 Jun;57(6):1510-6.
• Benefits of Artificially Induced Pleural Effusion and/or Ascites for Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma Located on the Liver Surface and in the Hepatic Dome.
  著者名：Iwai S, Sakaguchi H, Fujii H, Kobayashi S, Morikawa H, Enomoto M, Tamori A, Kawada N.
  出版物名：Hepatogastroenterology. 2012 Mar-Apr;59(114):546-50.
• Response-guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2.
  著者名：Yamaguchi Y, Tamori A, Tanaka Y, Iwai S, Kobayashi S, Fujii H, Morikawa H, Hagihara A, Enomoto M, Kawada N.
  出版物名：Hepatol Res. 2012 Jun;42(6):549-57.
• Inflammation and fibrogenesis in steatohepatitis.
  著者名：Fujii H, Kawada N.
  出版物名：J Gastroenterol. 2012 Mar;47(3):215-25.
• N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis.
  著者名：Kamada Y, Mori K, Matsumoto H, Kiso S, Yoshida Y, Shinzaki S, Hiramatsu N, Ishii M, Moriwaki K, Kawada N, Takehara T, Miyoshi E.
  出版物名：Glycobiology. 2012 Jun;22(6):778-87.
• MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
  著者名：Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N.
  出版物名：Gut. 2012 Jan 20. [Epub ahead of print]
• Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
  著者名：Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
  出版物名：BMC Gastroenterol. 2012 Jan 5;12:2.
• Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway.
  著者名：Uyama N, Iimuro Y, Kawada N, Reynaert H, Suzumura K, Hirano T, Kuroda N, Fujimoto J.
  出版物名： Lab Invest. 2012 Jan;92(1):57-71.
• Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysis.
  著者名：Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N, Nakagawa M, Yatsuhashi H, Izumi N.
  出版物名：Antivir Ther. 2012;17(1):35-43.
• Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
  著者名：Tani Y, Aso H, Matsukura H, Tadokoro K, Tamori A, Nishiguchi S, Yoshizawa H, Shibata H; JRC NAT Screening Research Group.
  出版物名：Vox Sang.2012 May;102(4):285-93.
• Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.
  著者名：Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N, Nakagawa M, Izumi N.
  出版物名：J Hepatol. 2012 Mar;56(3):602-8.
• Gemcitabine-induced Pleuropericardial Effusion in a Patient with Pancreatic Cancer.
  著者名：Kido H, Morizane C, Tamura T, Hagihara A, Kondo S, Ueno H, Okusaka T.
  出版物名：Jpn J Clin Oncol. 2012 Jul 10. [Epub ahead of print]
• Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases.
  著者名：Naganuma A, Mayahara H, Morizane C, Ito Y, Hagihara A, Kondo S, Ueno H, Itami J, Okusaka T.
  出版物名：Jpn J Clin Oncol. 2012 Jul;42(7):640-5. Epub 2012 Apr 23.
• Role of miR-19b and its target mRNAs on 5-fluorouracil resistance in colon cancer cells
  著者名：Kurokawa K, Tanahashi T, Iima T, Yamamoto Y, Akaike, Y, Nishida K, Masuda K, Kuwano Y, Murakami Y, Fukushima M, Rokutan K.
  出版物名： J Gastoroenterol. 2012 Mar 1
• Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b.
  著者名：Toyoda H, Kumada T, Tada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.
  出版物名：J Med Virol. 2012 Jan;84(1):61-70. doi: 10.1002/jmv.22272.
• Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically-resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.
  著者名：Toyoda H, Kumada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.
  出版物名：J Med Virol 2012; 84: 61-70

2012 和文

タイトル・著者

• 急性肝不全を呈するマクロファージ活性化症候群を合併した成人発症Still病の1例(原著論文)
  Author：藤井英樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学)、武田翔伍、浅井哲、林良樹、今西久幹、榎本大、石井正光、日野雅之、根来伸夫、荒川哲男、河田則文
  Source：肝臓(0451-4203)53巻3号 Page155-163(2012.03)
• 抗ウイルス薬-最新の動向-】 抗ウイルス薬の特性と適応・使い分け　抗肝炎ウイルス薬、インターフェロン製剤　インターフェロン製剤(解説/特集)
  Author：田守昭博(大阪市立大学 大学院医学研究科肝胆膵病態内科学)、河田則文
  Source：日本臨床(0047-1852)70巻4号 Page620-624(2012.04)
• 【肝硬変Update-肝硬変死の根絶をめざして】 病態の理解　肝線維化の機序とその制御(解説/特集)　
  Author：元山宏行(大阪市立大学 大学院医学研究科肝胆膵病態内科学)、河田則文
  Source：医学のあゆみ(0039-2359)240巻9号 Page699-704(2012.03)
• インターフェロンβ治療が無効であったC型肝炎合併血液透析患者に対し、ペグインターフェロンα-2aによる再治療でSVRが得られた1症例(原著論文/症例報告)
  Author：山川健次郎(仁真会白鷺病院)、小林佐和子、庄司繁市、山川智之
  Source：大阪透析研究会会誌(0912-6937)30巻1号 Page43-46(2012.03)
• 【新薬展望2012】 (第III部)治療における最近の新薬の位置付け（薬効別）新薬の広場　消化器癌治療薬(解説/特集)
  Author：小林佐和子(国立がん研究センター中央病院 肝胆膵腫瘍科)、上野秀樹、近藤俊輔、森実千種、奥坂拓志
  Source：医薬ジャーナル(0287-4741)48巻増刊 Page350-357(2012.01)